Cardiovascular disease risk among transgender women living with HIV in the United States.
Bennett J GosikerCatherine R LeskoAshleigh J RichHeidi M CraneMari M KitahataSari L ReisnerKenneth H MayerRob J FredericksenGeetanjali ChanderWm Christopher MathewsTonia C PoteatPublished in: PloS one (2020)
After adjustment for demographics and history of HIV care, prevalence of elevated CVD risk in TW was similar to CM and equal to or higher than in CW, depending operationalization of the sex variable. Future studies with CVD outcomes are needed to help clinicians accurately estimate CVD risk among TW with HIV.